Skip to Content
Merck
CN

T0682

Sodium taurohyodeoxycholate hydrate

≥98%

Synonym(s):

Taurohyodeoxycholic acid sodium salt hydrate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
C26H44NO6SNa · xH2O
CAS Number:
38411-85-7
Molecular Weight:
521.69 (anhydrous basis)
PubChem Substance ID:
24899908
NACRES:
NA.25
UNSPSC Code:
12161900
MDL number:
MFCD09263185

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Sodium taurohyodeoxycholate hydrate, ≥98%

InChI key

MJKUJELEPWZEGU-IGEKTTBWSA-M

SMILES string

O.[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

1S/C26H45NO6S.Na.H2O/c1-16(4-7-24(30)27-12-13-34(31,32)33)19-5-6-20-18-15-23(29)22-14-17(28)8-10-26(22,3)21(18)9-11-25(19,20)2;;/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);;1H2/q;+1;/p-1/t16-,17-,18+,19-,20+,21+,22+,23+,25-,26-;;/m1../s1

description

anionic

assay

≥98%

mol wt

521.69 g/mol (anhydrous basis)

application(s)

detection

Quality Level

100

Related Categories

Application

Sodium taurohyodeoxycholate hydrate has been used in a study to assess dose-response data for cytotoxicity, regenerative cell proliferation and secondary oxidative DNA damage in rat livers treated with furan. It has also been used in a study to investigate the use of an immobilized artificial membrane HPLC column to predict bile salt-membrane interactions.

General description

Sodium taurohyodeoxycholate hydrate is a taurine-amidated bile salt, which can be used as an anionic detergent.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCV2916
MKCP7202
MKCR3912
MKCP0150
MKCJ7175

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

P Loria et al.
Hepatology (Baltimore, Md.), 25(6), 1306-1314 (1997-06-01)
This study aimed to determine the effect in humans of taurohyodeoxycholic acid, a 6alpha-hydroxylated bile acid with hydrophilic properties, on bile lipid secretion. Four cholecystectomized patients who had gallstones and an interrupted enterohepatic circulation were intraduodenally infused with taurohyodeoxycholic and
M Angelico et al.
Scandinavian journal of gastroenterology, 30(12), 1178-1185 (1995-12-01)
Unconjugated bile salts currently available for gallstone dissolution are poorly effective. We evaluated in vitro the litholytic potency of taurine-amidated bile salts against human cholesterol gallstones. Seventy radiolucent gallstones with similar size and composition (cholesterol content, 70.1 +/- 0.9%) from
F Feletti et al.
Arzneimittel-Forschung, 43(8), 894-897 (1993-08-01)
The reproductive toxicity of taurohyodeoxycholic acid (3 alpha, 6 alpha-dihydroxy-5-beta-cholanoyl-2-amino-ethyl-sulfonic acid, THDCA, Io, Praxis, CAS 2958-04-5), a new synthetized biliary acid patented in Europe, Japan and the United States for prevention and therapy of gallstones and related symptoms, was assayed
M Angelico et al.
Digestive diseases and sciences, 39(11), 2389-2397 (1994-11-01)
Taurohyodeoxycholic acid is a natural 6 alpha-hydroxylated bile acid with an apparent hydrophilicity intermediate between those of tauroursodeoxycholic and taurocholic acids. We investigated in the rat the hepatobiliary metabolism, choleretic properties, and biliary maximum secretory rate (SRmax) of taurohyodeoxycholic in
M Paolini et al.
Hepatology (Baltimore, Md.), 30(3), 730-739 (1999-08-26)
We examined the effects of the administration of different bile acids on in vivo hepatic murine cytochrome P450 (CYP) content, nicotinamide adenine dinucleotide phosphate (NADPH)-CYP-reductase, and individual mixed-function oxidases (MFOs). Neither CYP level nor reductase were appreciably affected by single
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service